Opus Genetics Files 8-K for Other Events

Ticker: IRD · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1228627

Sentiment: neutral

Topics: 8-k, other-events

TL;DR

Opus Genetics filed an 8-K for 'Other Events' on March 4th. Details TBD.

AI Summary

Opus Genetics, Inc. filed an 8-K on March 4, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself. The company, formerly known as Ocuphire Pharma, Inc., is incorporated in Delaware and headquartered in Durham, NC.

Why It Matters

This 8-K filing indicates a material event has occurred for Opus Genetics, Inc., requiring public disclosure, though the specifics are not yet detailed.

Risk Assessment

Risk Level: medium — The filing indicates a significant event has occurred, but the lack of detail in the provided text creates uncertainty about its nature and impact.

Key Players & Entities

FAQ

What specific event(s) are being reported under 'Other Events' in this 8-K filing?

The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.

When was Opus Genetics, Inc. previously known as Ocuphire Pharma, Inc.?

The filing indicates the date of the name change from Ocuphire Pharma, Inc. to Opus Genetics, Inc. was November 9, 2020.

What is the principal executive office address for Opus Genetics, Inc.?

The principal executive offices are located at 8 Davis Drive, Suite 220, Durham, NC 27709.

What is the Commission File Number for Opus Genetics, Inc.?

The Commission File Number for Opus Genetics, Inc. is 001-34079.

What is the IRS Employer Identification Number for Opus Genetics, Inc.?

The IRS Employer Identification Number for Opus Genetics, Inc. is 11-3516358.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding Opus Genetics, Inc. (IRD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing